Medicare Enrolled

Dr. Markus Niederwanger, MD

Pain Medicine · Savannah, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
322 STEPHENSON AVE STE A, Savannah, GA 31405
9126445300
In practice since 2005 (20 years)
NPI: 1508858887 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Niederwanger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Niederwanger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Niederwanger

Dr. Markus Niederwanger is a pain medicine specialist in Savannah, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Niederwanger performed 1,083 Medicare services across 618 unique beneficiaries.

Between the years covered by Open Payments, Dr. Niederwanger received a total of $13,577 from 34 pharmaceutical and/or device companies across 505 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Niederwanger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 42% volume in GA $13,577 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,083
Medicare services
Top 42% in GA for pain medicine
618
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~54 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
361 $60 $186
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
176 $1 $5
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
125 $83 $278
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
94 $38 $111
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
61 $117 $427
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
46 $75 $577
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
43 $82 $844
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
43 $52 $500
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
27 $58 $226
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
22 $75 $978
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
18 $88 $1,093
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
18 $55 $253
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
17 $175 $686
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
16 $98 $943
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
16 $59 $240
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,577
Total received (2018-2024)
Avg $1,940/year across 7 years
Top 17% in GA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
505
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,577 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,368
2023
$2,800
2022
$959
2021
$1,174
2020
$628
2019
$1,572
2018
$3,077

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$2,833
Collegium Pharmaceutical, Inc.
$178
SPR Therapeutics, Inc
$77
ABBVIE INC.
$66
Nevro Corp.
$62
Abbott Laboratories
$47
Forte Bio-Pharma LLC
$30
Avanos Medical
$28
VERTEX PHARMACEUTICALS INCORPORATED
$24
PAINTEQ LLC
$23
Top 3 companies account for 91.7% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$7,416
Nevro Corp.
$1,594
BOSTON SCIENTIFIC CORPORATION
$864
Collegium Pharmaceutical, Inc.
$621
Abbott Laboratories
$527
Scilex Pharmaceuticals Inc.
$448
Sentynl Therapeutics, Inc.
$243
Daiichi Sankyo Inc.
$213
BioDelivery Sciences International, Inc.
$185
Forte Bio-Pharma LLC
$172
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$160
PFIZER INC.
$141
ABBVIE INC.
$134
Avanos Medical
$130
Indivior Inc.
$107
SPR Therapeutics, Inc
$77
Vertos Medical, Inc.
$66
AstraZeneca Pharmaceuticals LP
$57
SCILEX PHARMACEUTICALS INC.
$49
Stimwave Technologies Incorporated
$48
Purdue Pharma L.P.
$43
Shionogi Inc
$34
Medtronic USA, Inc.
$31
VERTEX PHARMACEUTICALS INCORPORATED
$24
Flexion Therapeutics, Inc.
$24
PAINTEQ LLC
$23
Allergan, Inc.
$22
Amgen Inc.
$21
IBSA Pharma Inc.
$19
PROTEGA PHARMACEUTIALS INC
$18
Medtronic, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$17
RedHill Biopharma Inc.
$17
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$14
Top 3 companies account for 72.7% of all-time payments
Associated products mentioned in payments ›
Aimovig · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · COOLIEF · COOLIEF* COOLED RADIOFREQUENCY · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · General - Pain Management · Horizant · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · Infinion 16 · LEVORPHANOL TARTRATE · LUCEMYRA · LYRICA · Levorphanol · Levorphanol Tartrate · Licart · MOVANTIK · Morphabond ER · Movantik · NA · NALOCET · Nalocet · Nucynta · Octrode SCS Leads · PAINTEQ · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · RELISTOR · ROXYBOND · S-Series SCS Leads · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPRINT PNS System · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · Superion Indirect Decompression System · Symproic · UBRELVY · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · Xtampza ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pain medicine specialist in Savannah?
Compare pain medicines in the Savannah area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
2
Per 100K population
0.7
County median income
$69,575
Nearest hospital
CANDLER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Niederwanger is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Niederwanger experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Niederwanger performed 361 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Niederwanger receive payments from pharmaceutical companies?
Yes. Dr. Niederwanger received a total of $13,577 from 34 companies across 505 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Niederwanger's costs compare to other pain medicines in Savannah?
Dr. Niederwanger's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Niederwanger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →